Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

dornase alfa inhalation solution

A highly purified solution of recombinant human deoxyribonuclease I (rhDNAse) with selective DNA cleaving activity. Administrated through inhalation of the nebulized solution, dornase alpha catalyzes DNA degradation in viscous airway secretions, which may render airway secretions less viscous, thus promoting the clearing of airway mucous plugging and improvement in pulmonary function.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	recombinant human deoxyribonuclease I inhalation solution
US brand name:	Pulmozyme
Foreign brand name:	Pulmozyme
Abbreviation:	rhDNase inhalation solution

dornase alfa inhalation solution

Search NCI's Drug Dictionary